3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Polycystic Ovary Syndrome
7
Neoplasms
6
Breast Neoplasms
6
Vomiting
2
Solid Tumors
2
Skin Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Diabetes Mellitus
2
Weight Gain
1
Venous Thromboembolism
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stem Cell Transplant Complications
1
Skin Toxicity
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pre-Eclampsia
1
Polycythemia Vera
1
Parathyroid Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Nausea
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Interventions
Peripheral Blood Stem Cell Transplantation
19
fludarabine phosphate
13
Mycophenolic Acid
12
Whole-Body Irradiation
11
Tacrolimus
11
Cyclosporine
9
Psychiatric Rehabilitation
8
Cyclophosphamide
8
Therapeutics
7
Rituximab
6
Methotrexate
6
Flow Cytometry
5
Busulfan
5
Vorinostat
4
Polymerase Chain Reaction
4
Methylprednisolone
4
Filgrastim
4
merphos
3
Radiotherapy
3
Ondansetron
3
Interferon-alpha
3
Etoposide
3
Early Intervention, Educational
3
Dexamethasone
3
Calcium Dobesilate
3
Bortezomib
3
Alemtuzumab
3
obinutuzumab
2
liposomal amphotericin B
2
immunotoxin HA22
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Leukemia, Hairy Cell
×
Tablets
×
Clear all
NCT04233034
2024-11-27
CLVer
Jaeb Center for Health Research
Phase 3
Completed
113 enrolled
42 charts